SKYRIZI® is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy
Single-Dose Pen
Manufacturer # 00074210001
Brand SKYRIZI®
Manufacturer AbbVie Inc
Country of Origin Germany
Application Monoclonal Antibody
Container Type Prefilled Auto-Injector
Dosage Form Injection
Generic Drug Code 49591
Generic Drug Name Risankizumab-rzaa
Is_Active_Vendor Y
Is_DSCSA N
Is_Discontinued N
Is_Medical_Device Y
Lot_Tracking_Flag N
NDC Number 00074210001
On_Allocation N
Product Dating McKesson Acceptable Dating: we will ship >= 180 days
Storage Requirements Requires Refrigeration
Strength 150 mg / mL
Supplier_ID 4384414
Type Subcutaneous
UNSPSC Code 51241200
Volume 1 mL
